MPS announced that its wholly owned subsidiary, MPS North America LLC has concluded the acquisition of 100% stake in Unbound Medicine Inc., USA for a total consideration of USD 16.5 million. Accordingly, Unbound Medicine, Inc., USA has become a wholly-owned step-down subsidiary of MPS. Powered by Capital Market - Live News

Net profit of MPS declined 12.80% to Rs 35.50 crore in the quarter ended December 2025 as against Rs 40.71 crore during the previous quarter ended December 2024. Sales declined 2.08% to Rs 182.49 crore in the quarter ended December 2025 as against Rs 186.36 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales182.49186.36 -2 OPM %31.5532.38 - PBDT59.3961.96 -4 PBT53.0955.09 -4 NP35.5040.71 -13 Powered by Capital Market - Live News

MPS will hold a meeting of the Board of Directors of the Company on 2 February 2026.Powered by Capital Market - Live News

Net profit of MPS rose 57.32% to Rs 55.44 crore in the quarter ended September 2025 as against Rs 35.24 crore during the previous quarter ended September 2024. Sales rose 9.42% to Rs 194.44 crore in the quarter ended September 2025 as against Rs 177.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales194.44177.70 9 OPM %31.1030.11 - PBDT62.4654.88 14 PBT56.3648.06 17 NP55.4435.24 57 Powered by Capital Market - Live News

MPS will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News